Newcastle Science City is committed to helping them to improve communications between the scientific and business communities and also with potential investors. Key to that initiative is the increasing use of the title Professor of Practice, which has been adopted at a number of leading research universities over the past decade.
American universities are already using Professors of Practice to enhance the quality of teaching by putting real world practitioners in front of students but Newcastle Science City has taken the idea to a new level. Our Professors of Practice at Newcastle University are scientist entrepreneurs with strong academic credentials and research interests, as well as commercial experience. As agents of change, the Professors of Practice work to foster new industrial networks, develop research programmes, identify commercial opportunities and act as a role model for staff and students.
Professor Dr David Leahy
Dr. David Leahy has more than 20 years scientific experience in the bio and chemo-informatics applied to drug discovery. After working for world leaders such as AstraZeneca,
David went on to form Cyprotex to pursue his ideas for improved technology for drug discovery.
Under David's leadership, Cyprotex grew and was eventually floated on the London Stock Exchange. David now acts independently of Cyprotex working with Universities and commercial organisations throughout Europe and the United States on developing new research programmes in the use of autonomous agent architectures for automation of molecular design processes.
Professor Dr Andrew Lyddiatt
Dr. Andrew Lyddiatt has more than 30 year scientific experience in biochemical engineering. With a PhD in molecular and cellular biology from Durham University, Andrew established a life-long fascination with the influence of molecular structural determinants upon production, purification and characterisation of macro and mega molecular assemblies. He pursued such interests in postdoctoral research on microbial, animal and human proteins at Trinity College Dublin, Imperial College and in the commercial environment of Cambridge Life Sciences on the Cambridge Science Park. He established the Biochemical Recovery Group at the University of Birmingham in 1985, and as Professor of Process Biotechnology, subsequently directed the Birmingham Centre for Bioprocess Engineering. In February 2003, he joined Millipore Biopharmaceutical Division in County Durham and managed 25 R&D personnel in the UK and US to develop chromatographic media, related bio separation hardware and procedures for applications in biopharmaceutical manufacture.
Professor Peter Gore
Peter Gore has an Engineering Design Master degree from Loughborough University and has more than 25 years experience in medical product design. In 1990 he became the Director of R&D and Quality for the BOC Group in Atlanta. In 1993, he founded and became the Managing Director of Cane & Able Ltd that specialised in assistive technology. In 2002, he founded ADL Smartcare Ltd to match people and technological solutions currently available.
